Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evana López

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
JAMA Network Open|July 30, 2025
Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-AnalysisFredrik Hieronymus, Evana López, Helena Werin Sjögren, et al.
Lakartidningen|April 4, 2024
[Psychedelic psychiatry]Evana López, Hampus Yngwe, Maria Beckman, et al.
Bjpsych Open|June 9, 2026
The relation between observer-rated depressive symptoms and patient-rated quality of life after six weeks of antidepressant treatment: pooled patient-level analysis of mirtazapine trialsHelena Werin Sjögren, Evana López, Alexander Lisinski, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
JAMA Network Open|July 30, 2025
Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-AnalysisFredrik Hieronymus, Evana López, Helena Werin Sjögren, et al.
Lakartidningen|April 4, 2024
[Psychedelic psychiatry]Evana López, Hampus Yngwe, Maria Beckman, et al.
Bjpsych Open|June 9, 2026
The relation between observer-rated depressive symptoms and patient-rated quality of life after six weeks of antidepressant treatment: pooled patient-level analysis of mirtazapine trialsHelena Werin Sjögren, Evana López, Alexander Lisinski, et al.
Pageof 1